(MedPage Today) — Members of an FDA expert panel urged the agency to expand labeling for testosterone replacement therapy and remove its classification as a controlled substance.
Like previous FDA expert panels, the group was convened by Commissioner…
Source link : https://www.medpagetoday.com/urology/urology/118961
Author :
Publish date : 2025-12-11 19:15:00
Copyright for syndicated content belongs to the linked Source.
